With Restructuring, Ray Elliott Makes Boston Scientific His Own
This article was originally published in The Gray Sheet
Executive Summary
Facing what promises to be a very challenging 2010, Boston Scientific is revamping its management and cost structures, making major layoffs and setting the stage for a series of targeted divestures and acquisitions
You may also be interested in...
St. Jude Restructuring Will Cut 300 Jobs, Save Up To $60 Million In 2013
Move will realign four product divisions into two new operating units to support growth opportunities, help offset impact of 2.3% device tax set to take effect next year.
Boston Scientific Lays Out Near-Term Growth Plan
Boston Scientific’s ongoing effort to reorganize and recharge its product pipeline and reduce manufacturing costs will restore higher revenue growth over the next few years, executives said during a Nov. 19 day-long investor presentation.
Boston Scientific Lays Out Near-Term Growth Plan
Boston Scientific’s ongoing effort to reorganize and recharge its product pipeline and reduce manufacturing costs will restore higher revenue growth over the next few years, executives said during a Nov. 19 day-long investor presentation.